Back to 
CIBC Bancorp USA Inc.
CIBC Bancorp USA Inc.
NVCT2 quarters
Position history for CIBC Bancorp USA Inc.'s holdings in NUVECTIS PHARMA INC
CIBC Bancorp USA Inc. holds 67,155 shares of NVCT (NUVECTIS PHARMA INC), worth $917,661 as of 2026-Q2. The position was increased (+161.7% shares). NVCT represents 0.0% of CIBC Bancorp USA Inc.'s portfolio.
Current Value
$917,661
Current Shares
67,155
Total Value Change
+$719,293
Total Shares Change
+41,493
Quarter-by-Quarter History
Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC